Explore the categories so you can find more about your search.

Categorie > Cancer / Oncology

Radiation Oncology Associates Of NY First In New York To Offer Patients A New, Faster Radiotherapy For Treating Cancer

Categorie : Cancer / Oncology
Two prostate cancer patients became the first people in New York to receive a faster, more comfortable form of highly accurate radiotherapy in pioneering treatments at Radiation Oncology Associates of New York (a Division of Integrated Medical Professionals, PLLC). ...

read more Two prostate cancer patients became the first people in New York to receive a faster, more comfortable form of highly accurate radiotherapy in pioneering treatments at Radiation Oncology Associates of New York (a Division of Integrated Medical Professionals, PLLC). read more Tue Jul 2008 Tue Jul 2008

Control Switches Found For Immune Cells That Fight Cancer, Viral Infection

Categorie : Cancer / Oncology
Medical science may be a significant step closer to climbing into the driver's seat of an important class of immune cells, researchers at Washington University School of Medicine in St. Louis report in Nature Immunology. The researchers showed that a single protein, HS1, enables key functions of ...

read more Medical science may be a significant step closer to climbing into the driver's seat of an important class of immune cells, researchers at Washington University School of Medicine in St. Louis report in Nature Immunology. The researchers showed that a single protein, HS1, enables key functions of read more Tue Jul 2008 Tue Jul 2008

Cancer Drug Promising Against Graft-vs.-Host Disease

Categorie : Cancer / Oncology
A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants. Plans are under way at U-M for an in ...

read more A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants. Plans are under way at U-M for an in read more Tue Jul 2008 Tue Jul 2008

Skin Mole Analysis Using The Internet - A New Service By Opticom Data Research

Categorie : Cancer / Oncology
Opticom Data Research performs skin mole analysis on mole images that are submitted through its Web site. The company uses its MoleSense software to analyze these moles and then an automated process compares the analysis results to 100s of skin cancer images available on the Internet. This is a new ...

read more Opticom Data Research performs skin mole analysis on mole images that are submitted through its Web site. The company uses its MoleSense software to analyze these moles and then an automated process compares the analysis results to 100s of skin cancer images available on the Internet. This is a new read more Tue Jul 2008 Tue Jul 2008

Minorities, Rural Residents In Maryland Less Likely To Be Cancer Clinical Trial Participants, Study Finds

Categorie : Cancer / Oncology
Minorities and rural residents in Maryland are underrepresented in cancer clinical trials and blacks' rate of participation is dropping, according to a study published in the July issue of the Journal of Clinical Oncology, the Baltimore Sun reports. ...

read more Minorities and rural residents in Maryland are underrepresented in cancer clinical trials and blacks' rate of participation is dropping, according to a study published in the July issue of the Journal of Clinical Oncology, the Baltimore Sun reports. read more Tue Jul 2008 Tue Jul 2008

Long Term Pegylated Interferon Alfa-2b Therapy In Stage III Melanoma Demonstrated Significant And Sustained Impact On Relapse-Free Survival

Categorie : Cancer / Oncology
Schering-Plough (NYSE: SGP) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival (RFS), according to results of a randomized phase III trial published in The Lancet. ...

read more Schering-Plough (NYSE: SGP) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival (RFS), according to results of a randomized phase III trial published in The Lancet. read more Tue Jul 2008 Tue Jul 2008

Melanoma On The Rise Among Young Women In The US

Categorie : Cancer / Oncology
A review of 30 years of surveillance and epidemiological records shows that incidence of melonoma, the most lethal form of skin cancer, is increasing among young Caucasian women but not among young men in the US. The reviewers did not establish if this is due to increased exposure to ultr ...

read more A review of 30 years of surveillance and epidemiological records shows that incidence of melonoma, the most lethal form of skin cancer, is increasing among young Caucasian women but not among young men in the US. The reviewers did not establish if this is due to increased exposure to ultr read more Tue Jul 2008 Tue Jul 2008

Sex, Death And Rock & Roll - Teen Movie Makers Help Create Cutting Edge Anti-smoking Films

Categorie : Cancer / Oncology
Three hard hitting films - designed by teenagers for teenagers - were launched after a national competition helped uncover the next generation of British film makers. Cancer Research UK and Channel 4's 4Talent launched a joint initiative - funded by the Department of Health - called BREATHE to pro ...

read more Three hard hitting films - designed by teenagers for teenagers - were launched after a national competition helped uncover the next generation of British film makers. Cancer Research UK and Channel 4's 4Talent launched a joint initiative - funded by the Department of Health - called BREATHE to pro read more Tue Jul 2008 Tue Jul 2008

Study Finds That Significant Proportion Of Men Told Wife's Cancer Was Incurable Late Or Not At All

Categorie : Cancer / Oncology
A study conducted in Sweden found that more than 40 percent of widowers in that country whose wives died from cancer four or five years earlier reported they were either never told that their spouse's cancer was incurable, or they heard this information during the last week of her life. Eighty-six p ...

read more A study conducted in Sweden found that more than 40 percent of widowers in that country whose wives died from cancer four or five years earlier reported they were either never told that their spouse's cancer was incurable, or they heard this information during the last week of her life. Eighty-six p read more Tue Jul 2008 Tue Jul 2008

Molecular Evidence Of The Independent Origin Of Multiple Wilms Tumors In A Case Of WAGR Syndrome

Categorie : Cancer / Oncology
UroToday.com - A study by Dr. Uccini, et al., evaluated the molecular evidence of the independent origin of multiple Wilms tumors in a patient who has WAGR syndrome. The paper was a description of the procedure, technique and its results. They had one patient who was 1 year of age. This child dev ...

read more UroToday.com - A study by Dr. Uccini, et al., evaluated the molecular evidence of the independent origin of multiple Wilms tumors in a patient who has WAGR syndrome. The paper was a description of the procedure, technique and its results. They had one patient who was 1 year of age. This child dev read more Tue Jul 2008 Tue Jul 2008

Discovery Of Mechanism That Explains How Cancer Enzyme Winds Up On Ends Of Chromosomes

Categorie : Cancer / Oncology
Human cancer cells divide and conquer. Unless physicians can control that division with surgery, chemotherapy or radiation, the wildly dividing cells will eventually destroy a person's life. Researchers have known for some time that an enzyme called telomerase is crucial to cancer's progress. ...

read more Human cancer cells divide and conquer. Unless physicians can control that division with surgery, chemotherapy or radiation, the wildly dividing cells will eventually destroy a person's life. Researchers have known for some time that an enzyme called telomerase is crucial to cancer's progress. read more Tue Jul 2008 Tue Jul 2008

BioAlliance Pharma Launches Loramyc(R) In The UK, Germany And Denmark

Categorie : Cancer / Oncology
BioAlliance Pharma SA (Euronext Paris - BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced the launch of its lead product Loramyc® on the British, German and Danish markets. "This simultaneous product launch in three Europea ...

read more BioAlliance Pharma SA (Euronext Paris - BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced the launch of its lead product Loramyc® on the British, German and Danish markets. read more Tue Jul 2008 Tue Jul 2008

UAB Joins Elite Brain Cancer Research Group

Categorie : Cancer / Oncology
Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a ki ...

read more Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a ki read more Tue Jul 2008 Tue Jul 2008

Cancer Drug Reformulation Featured In Prestigious Journal

Categorie : Cancer / Oncology
Dr. Yuri Lvov, a professor of chemistry and T. Pipes endowed chair in micro and nanosystems at Louisiana Tech University, and Anshul Agarwal, a Louisiana Tech doctoral candidate in biomedical engineering feature their cancer drug reformulation work in the most recent issue of Pharma Focus Asia, one ...

read more Dr. Yuri Lvov, a professor of chemistry and T. Pipes endowed chair in micro and nanosystems at Louisiana Tech University, and Anshul Agarwal, a Louisiana Tech doctoral candidate in biomedical engineering feature their cancer drug reformulation work in the most recent issue of Pharma Focus Asia, one read more Tue Jul 2008 Tue Jul 2008

Four New Research Grants Awarded To Help Fight 'Taboo' Disease, Prostate Cancer, UK

Categorie : Cancer / Oncology
The Prostate Cancer Charity is supporting four new research projects across the UK. The projects, totaling over £500,000, aim to increase scientific understanding of prostate cancer and benefit current and future generations of men affected by the disease and their partners and families. ...

read more The Prostate Cancer Charity is supporting four new research projects across the UK. The projects, totaling over £500,000, aim to increase scientific understanding of prostate cancer and benefit current and future generations of men affected by the disease and their partners and families. read more Tue Jul 2008 Tue Jul 2008

Researchers Hone Technique To KO Pediatric Brain Tumors - Slow Release Is Key

Categorie : Cancer / Oncology
An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Te ...

read more An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Te read more Tue Jul 2008 Tue Jul 2008

Eight-Year Melanoma Remission Is Among Early Cancer Treatment Results

Categorie : Cancer / Oncology
A newly available treatment already has benefited several individuals with aggressive malignancies. Offered through NeoPlas Innovation, this regimen has arrested or eradicated tumors in more than 80% of initial patients. Director of Research Dr. Stephen Cantrell emphasized that ...

read more A newly available treatment already has benefited several individuals with aggressive malignancies. Offered through NeoPlas Innovation, this regimen has arrested or eradicated tumors in more than 80% of initial patients. Director of Research Dr. Stephen Cantrell emphasized that read more Tue Jul 2008 Tue Jul 2008

Brain Cancer Study: Magnitude Of Post-Vaccine Immune Response Linked To Clinical Outcomes

Categorie : Cancer / Oncology
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the ...

read more Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the read more Tue Jul 2008 Tue Jul 2008

Device Can Read Genetic Signature Of Circulating Tumour Cells To Guide Therapy

Categorie : Cancer / Oncology
A microchip-based device that detects and analyses tumour cells in the bloodstream proved effective in determining the genetic signature of lung tumours, allowing identification of patients appropriate for targeted treatment in a pilot study in patients with non-small-cell lung cancer (NSCLC). ...

read more A microchip-based device that detects and analyses tumour cells in the bloodstream proved effective in determining the genetic signature of lung tumours, allowing identification of patients appropriate for targeted treatment in a pilot study in patients with non-small-cell lung cancer (NSCLC). read more Tue Jul 2008 Tue Jul 2008

Wavelets Crunch Through Doctors' Day Long Struggle To Diagnose Brain Tumors

Categorie : Cancer / Oncology
Today if doctors devote a full day to analysis and expert thought, they may be able to provide just half a dozen patients with a diagnosis of the precise type of brain tumour they face. Now researchers at the University of Warwick have devised an automated technique that can give a preliminary analy ...

read more Today if doctors devote a full day to analysis and expert thought, they may be able to provide just half a dozen patients with a diagnosis of the precise type of brain tumour they face. Now researchers at the University of Warwick have devised an automated technique that can give a preliminary analy read more Thu Jun 2008 Thu Jun 2008

1 | 2 | 3 | 4 next >>>



     


Custom Search